Bank of New York Mellon Corp acquired a new position in shares of Arteris, Inc. (NASDAQ:AIP – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 77,281 shares of the company’s stock, valued at approximately $580,000. Bank of New York Mellon Corp owned 0.20% of Arteris at the end of the most recent quarter.
A number of other hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in shares of Arteris by 0.3% during the first quarter. Vanguard Group Inc. now owns 1,146,224 shares of the company’s stock valued at $8,390,000 after buying an additional 3,242 shares in the last quarter. Victory Capital Management Inc. acquired a new position in shares of Arteris in the 4th quarter valued at about $60,000. GSA Capital Partners LLP increased its holdings in shares of Arteris by 26.9% in the 1st quarter. GSA Capital Partners LLP now owns 132,952 shares of the company’s stock valued at $973,000 after purchasing an additional 28,165 shares during the period. Acadian Asset Management LLC boosted its holdings in shares of Arteris by 28.1% during the first quarter. Acadian Asset Management LLC now owns 534,472 shares of the company’s stock worth $3,911,000 after purchasing an additional 117,312 shares during the period. Finally, Silvercrest Asset Management Group LLC grew its position in Arteris by 25.2% during the first quarter. Silvercrest Asset Management Group LLC now owns 711,903 shares of the company’s stock valued at $5,211,000 after purchasing an additional 143,385 shares in the last quarter. 64.36% of the stock is owned by hedge funds and other institutional investors.
Arteris Trading Down 0.7 %
Shares of NASDAQ:AIP opened at $7.40 on Tuesday. Arteris, Inc. has a 1 year low of $4.20 and a 1 year high of $9.54. The firm has a fifty day moving average price of $7.76 and a 200 day moving average price of $7.60. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 0.17. The stock has a market capitalization of $284.74 million, a PE ratio of -7.18 and a beta of 1.12.
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on AIP. Westpark Capital reissued a “buy” rating and set a $11.00 target price on shares of Arteris in a research note on Wednesday, July 31st. Rosenblatt Securities reaffirmed a “buy” rating and issued a $15.00 target price on shares of Arteris in a research report on Monday, August 5th.
View Our Latest Analysis on Arteris
Insider Buying and Selling
In other Arteris news, COO Laurent R. Moll sold 37,561 shares of the business’s stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $7.49, for a total transaction of $281,331.89. Following the completion of the transaction, the chief operating officer now owns 544,468 shares of the company’s stock, valued at approximately $4,078,065.32. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Arteris news, COO Laurent R. Moll sold 37,561 shares of Arteris stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $7.49, for a total value of $281,331.89. Following the transaction, the chief operating officer now directly owns 544,468 shares of the company’s stock, valued at approximately $4,078,065.32. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO K Charles Janac sold 9,168 shares of the stock in a transaction that occurred on Wednesday, July 3rd. The shares were sold at an average price of $7.23, for a total value of $66,284.64. Following the completion of the sale, the chief executive officer now directly owns 296,070 shares of the company’s stock, valued at $2,140,586.10. The disclosure for this sale can be found here. In the last three months, insiders sold 143,753 shares of company stock valued at $1,049,619. Company insiders own 33.70% of the company’s stock.
Arteris Profile
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
See Also
- Five stocks we like better than Arteris
- How to Start Investing in Real Estate
- The Average 401k Balance by Age Explained
- Technology Stocks Explained: Here’s What to Know About Tech
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- High Flyers: 3 Natural Gas Stocks for March 2022
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Want to see what other hedge funds are holding AIP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arteris, Inc. (NASDAQ:AIP – Free Report).
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.